Adaptimmune Therapeutics Plc ADR (ADAP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

60 JUBILEE AVENUE ABINGDON, OXFORDSHIRE, UNITED KINGDOM OX14 4RX

Adaptimmune Therapeutics Plc is a clinical-stage biopharmaceutical company. The Company develops novel cancer immunotherapy products based on T-cell receptor platform that helps to identify cancer targets. Adaptimmune Therapeutics serves customers worldwide.

Data based on most recent fiscal year report
Market Cap433.417 Million Shares Outstanding104.69 Million Avg Volume871.371 Thousand
1-Yr BETA vs S&P TR3.205 Current Ratio9.46 Quick Ratio9.46
View SEC Filings from ADAP instead.

View recent insider trading info

Funds Holding ADAP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADAP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

418.5 Thousand total shares from 11 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TAYTON-MARTIN HELEN KATRINA CHIEF BUSINESS OFFICER

  • Officer
0 2020-01-16 2

RAWCLIFFE ADRIAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-01-16 5

BERTRAND WILLIAM C JR CHIEF OPERATING OFFICER

  • Officer
0 2020-01-16 3

LUNGER JOHN CHIEF PATIENT SUPPLY OFFICER

  • Officer
0 2020-01-16 5

NORRY ELLIOT CHIEF MEDICAL OFFICER

  • Officer
0 2020-01-16 3

NOBLE JAMES

  • Director
0 2020-01-13 2

THOMPSON PETER A.

  • Director
  • 10% Owner
0 2020-01-02 0

ALLEVA LAWRENCE M

  • Director
0 2020-01-02 1

MOTT DAVID M

  • Director
  • 10% Owner
0 2020-01-02 1

BARRIS PETER J

  • Director
849,527 2019-12-26 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
2,052,454 2019-12-24 0

BEHBAHANI ALI

  • 10% Owner
2,052,454 2019-12-24 1

BASKETT FOREST

  • 10% Owner
2,052,454 2019-12-24 0

SONSINI PETER W.

  • 10% Owner
2,052,454 2019-12-24 0

SANDELL SCOTT D

  • 10% Owner
2,052,454 2019-12-24 0

ZAKS TAL ZVI CHIEF MEDICAL OFFICER

  • Officer
104,770 2019-12-12 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP V LLC

  • Director
  • 10% Owner
9,619,791 2019-12-11 0

KERINS PATRICK J

  • 10% Owner
9,569,451 2019-12-09 0

DUNCAN BARBARA GAYLE

  • Director
0 2019-11-13 1

SIGAL CHARLES ELLIOTT

  • Director
0 2019-10-01 1

GARONE MICHAEL INTERIM CFO

  • Officer
0 2019-10-01 1

AMADO RAFAEL EVP OF R&D AND CMO

0 2019-09-03 1

KERR GILES FRANCIS BERTRAM

  • Director
0 2019-07-02 1

FUREY JOHN

  • Director
0 2019-07-02 1

BARRETT M JAMES

  • Director
0 2019-05-30 0

BINDER-SCHOLL GWENDOLYN KNOWLTON CHIEF TECHNOLOGY OFFICER

  • Officer
2,487 2019-01-14 0

VISWANATHAN RAVI

  • 10% Owner
5,000,000 2018-10-17 0

NEW ENTERPRISE ASSOCIATES 14, L.P.

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
82,978,668 2018-09-07 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP V LLC

ISALY SAMUEL D

  • Director
941,000 2017-12-08 0

KOLLURI KRISHNA KITTU

  • 10% Owner
5,215,128 2016-12-19 0

WELLER HARRY R

  • 10% Owner
3,490,073 2016-10-31 0

KNOWLES JONATHAN KENNETH CHARLES

  • Director
0 2016-08-11 0

LAING IAN MICHAEL

  • Director
0 2016-08-11 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

NORRY ELLIOT - Officer CHIEF MEDICAL OFFICER

2020-01-16 A 135,600 a 135,600 0.00 direct

TAYTON-MARTIN HELEN KATRINA - Officer CHIEF BUSINESS OFFICER

2020-01-16 A 1,257,744 a 1,257,744 0.00 direct

RAWCLIFFE ADRIAN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-01-16 A 561,792 a 561,792 0.00 direct

BERTRAND WILLIAM C JR - Officer CHIEF OPERATING OFFICER

2020-01-16 A 1,257,744 a 1,257,744 0.00 direct

NORRY ELLIOT - Officer CHIEF MEDICAL OFFICER

2020-01-16 A 201,600 a 201,600 0.00 direct

LUNGER JOHN - Officer CHIEF PATIENT SUPPLY OFFICER

2020-01-16 A 280,896 a 280,896 0.00 direct

RAWCLIFFE ADRIAN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-01-16 A 2,515,536 a 2,515,536 0.00 direct

TAYTON-MARTIN HELEN KATRINA - Officer CHIEF BUSINESS OFFICER

2020-01-16 A 280,896 a 280,896 0.00 direct

LUNGER JOHN - Officer CHIEF PATIENT SUPPLY OFFICER

2020-01-16 A 1,257,744 a 1,257,744 0.00 direct

BERTRAND WILLIAM C JR - Officer CHIEF OPERATING OFFICER

2020-01-16 A 280,896 a 280,896 0.00 direct

NORRY ELLIOT - Officer CHIEF MEDICAL OFFICER

2020-01-14 S 911 $5.13 d 1,326 1,326.00 direct

LUNGER JOHN - Officer CHIEF PATIENT SUPPLY OFFICER

2020-01-14 S 1,144 $5.13 d 1,681 1,681.00 direct

RAWCLIFFE ADRIAN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-01-14 S 3,236 $5.13 d 3,166 3,166.00 direct

BERTRAND WILLIAM C JR - Officer CHIEF OPERATING OFFICER

2020-01-14 S 2,397 $5.13 d 3,605 3,605.00 direct

TAYTON-MARTIN HELEN KATRINA - Officer CHIEF BUSINESS OFFICER

2020-01-13 S 50,000 $4.00 d 0 0.00 direct

NOBLE JAMES - Director

2020-01-13 S 200,000 $5.00 d 0 0.00 direct

NOBLE JAMES - Director

2020-01-13 S 100,000 $4.00 d 0 0.00 direct

TAYTON-MARTIN HELEN KATRINA - Officer CHIEF BUSINESS OFFICER

2020-01-13 S 50,000 $5.00 d 0 0.00 direct

BERTRAND WILLIAM C JR - Officer CHIEF OPERATING OFFICER

2020-01-06 S 3,731 $1.20 d 5,632 5,632.00 direct

LUNGER JOHN - Officer CHIEF PATIENT SUPPLY OFFICER

2020-01-06 S 1,148 $1.20 d 1,677 1,677.00 direct

RAWCLIFFE ADRIAN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-01-06 S 5,900 $1.20 d 5,804 5,804.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments